AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market
Holding ANTX?
Track your performance easily

AN2 Therapeutics, Inc. (ANTX) Financial Statements

84 Followers

AN2 Therapeutics, Inc. Financial Overview

AN2 Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.262; its P/E ratio is -0.49; AN2 Therapeutics, Inc. is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -14.44M$ -18.30M$ -18.82M$ -18.18M$ -15.80M
EBITDA$ -14.44M$ -18.30M$ -18.82M$ -18.18M$ -15.80M
Net Income Common Stockholders$ -14.44M$ -16.62M$ -16.90M$ -16.71M$ -15.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 104.57M$ 114.22M$ 107.30M$ 123.80M$ 95.25M
Total Assets$ 108.48M$ 121.26M$ 138.74M$ 153.81M$ 98.91M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 13.00K
Net Debt$ -104.57M$ -114.22M$ -107.30M$ -123.80M$ -95.23M
Total Liabilities$ 10.13M$ 10.66M$ 14.04M$ 14.84M$ 11.16M
Stockholders Equity$ 98.35M$ 110.60M$ 124.70M$ 138.97M$ 87.76M
Cash Flow-
Free Cash Flow$ -14.38M$ -17.59M$ -17.07M$ -11.80M$ -12.82M
Operating Cash Flow$ -14.38M$ -17.59M$ -17.07M$ -11.80M$ -12.82M
Investing Cash Flow$ 16.46M$ 26.29M$ 420.00K$ -62.46M$ 7.88M
Financing Cash Flow-$ 349.00K$ -321.00K$ 66.07M$ 19.05M
Currency in USD

AN2 Therapeutics, Inc. Earnings and Revenue History

AN2 Therapeutics, Inc. Debt to Assets

AN2 Therapeutics, Inc. Cash Flow

AN2 Therapeutics, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis